Jennifer Humes - 20 Mar 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Chief Accounting Officer
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Jennifer Humes
Issuer symbol
ROIV
Transactions as of
20 Mar 2025
Net transactions value
$0
Form type
4
Filing time
24 Mar 2025, 21:01:56 UTC
Previous filing
25 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +112,255 $0.000000 112,255 20 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +115,108 $0.000000 115,108 20 Mar 2025 Common Shares 115,108 $10.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of March 20, 2025. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date.
F2 Award of stock options to purchase Common Shares with a vesting commencement date of February 20, 2025. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date.